SeaStar Medical Holding Corporation – NASDAQ:ICU

Add to watchlist

$0.81

-1.23

-60.31%

Market closed

Open in about 11 hours

-76.28%

month

-76.28%

quarter

+346.39%

year

Market Cap	8.79M
Enterprise value	N/A

P/E	N/A
EV/Sales	N/A
EV/EBITDA	N/A
Price/Sales	N/A
Price/Book	N/A
PEG ratio	N/A
EPS	-1.07

Revenue	N/A
EBITDA	-13.43M
Income	-33.66M
Revenue Q/Q	N/A
Revenue Y/Y	N/A

Profit margin	0%
Oper. margin	0%
Gross margin	0%
EBIT margin	0%
EBITDA margin	N/A

Get more financial ratios!

Every financial ratio you might need
10 years history
Forward ratios (Analysts estimates)

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

SeaStar Medical Holding Corporation (NASDAQ:ICU): Profit margin
Jun 2023	0	-3.66M
Sep 2023	0	-7.42M
Dec 2023	0	-9.87M
Mar 2024	0	-12.69M

SeaStar Medical Holding Financials Estimate

Q Y

SeaStar Medical Holding Corporation (NASDAQ:ICU): Analyst Estimates
2025	1M	-4.55M	-455.08%

Analysts Price target
Financials & Ratios estimates

SeaStar Medical Holding Corporation (NASDAQ:ICU): Debt to assets
Jun 2023	2334000	13.78M	590.49%
Sep 2023	2247000	18.15M	807.74%
Dec 2023	3513000	17.38M	494.82%
Mar 2024	7740000	12.21M	157.79%

SeaStar Medical Holding Corporation (NASDAQ:ICU): Cash Flow
Jun 2023	-2.16M	1.45M
Sep 2023	-1.33M	1.39M
Dec 2023	-4.48M	4.58M
Mar 2024	-3.48M	8.33M

SeaStar Medical Holding alternative data

SeaStar Medical Holding
Employees

SeaStar Medical Holding Corporation (NASDAQ:ICU): Employee count
Aug 2023	9
Sep 2023	9
Oct 2023	9
Nov 2023	9
Dec 2023	9
Jan 2024	9
Feb 2024	9
Mar 2024	9
Apr 2024	9
May 2024	12
Jun 2024	12
Jul 2024	12

SeaStar Medical Holding
Hedge Funds Holdings Q1 2023

1.10% -17.18%

of ICU is owned by hedge funds

7 -3

hedge funds hold ICU stock

90.02K -1.23M

shares is hold by hedge funds

ICU hedge funds holdings changes

SeaStar Medical Holding
Insider Trading

SeaStar Medical Holding Corporation (NASDAQ:ICU): Insider trades (number of shares)
Period	Buy	Sel
Sep 2024	1000	0
Nov 2024	4250	0

Transaction	Date	Insider	Security	Shares	Price per share	Total value
Purchase	18 Nov 2024	CHUNG KEVIN officer: Chief Medical Officer officer: Chief Medical Officer	Common Stock, par value $0.0001 per share	4,250	$1.99	$8,458
Purchase	30 Sep 2024	CHUNG KEVIN officer: Chief Medical Officer officer: Chief Medical Officer	Common Stock, par value $0.0001 per share	1,000	$4.26	$4,258
Purchase	22 Nov 2023	VAN HEEL KENNETH director director	Common Stock, par value $0.0001 per share	100,000	$0.4	$40,000
Purchase	30 May 2023	CHUNG KEVIN officer: Chief Medical Officer officer: Chief Medical Officer	Common Stock, par value $0.0001 per share	5,093	$0.47	$2,394
Purchase	30 May 2023	CHUNG KEVIN officer: Chief Medical Officer officer: Chief Medical Officer	Common Stock, par value $0.0001 per share	4,000	$0.48	$1,920
Purchase	30 May 2023	CHUNG KEVIN officer: Chief Medical Officer officer: Chief Medical Officer	Common Stock, par value $0.0001 per share	2,300	$0.48	$1,093
Purchase	30 May 2023	CHUNG KEVIN officer: Chief Medical Officer officer: Chief Medical Officer	Common Stock, par value $0.0001 per share	1,150	$0.48	$546
Purchase	25 May 2023	RUSSELL RICHARD D. director director	Common Stock, par value $0.0001 per share	20,000	$0.5	$10,000
Purchase	18 May 2023	CHUNG KEVIN officer: Chief Medical Officer officer: Chief Medical Officer	Common Stock, par value $0.0001 per share	7,500	$0.7	$5,250
Purchase	5 Apr 2022	CHUNG KEVIN officer: Chief Medical Officer officer: Chief Medical Officer	Common Stock, par value $0.0001 per share	3,760	$1.85	$6,956

ICU insider trading transactions

SeaStar Medical Holding
Latest News

Monday, 23 December 2024
07:00	SeaStar Medical Activates 14th Hospital for its Adult AKI Pivotal Trial	globenewswire.com
Wednesday, 11 December 2024
06:30	SeaStar Medical Projects Multibillion-Dollar Market Potential for its Selective Cytopheretic Device in Initial Target Indications	globenewswire.com
Wednesday, 4 December 2024
08:30	SeaStar Medical to Hold Business Update Conference Call on December 11, 2024	globenewswire.com
Tuesday, 26 November 2024
08:00	SeaStar Medical to Present at Noble Capital Markets' NobleCon20 on December 4, 2024	globenewswire.com
Friday, 22 November 2024
08:30	Leading Independent Proxy Advisory Firms ISS and Glass Lewis Support SeaStar Medical's Proposals to Ratify the Issuance of Shares and to Reduce the Number of Authorized Shares	globenewswire.com
Friday, 15 November 2024
08:30	SeaStar Medical Reaches Milestone of 100th QUELIMMUNE Commercial Device as Shipments Begin to its Third Hospital Customer	globenewswire.com
Wednesday, 13 November 2024
17:05	SeaStar Medical Reports Third Quarter 2024 Financial Results and Provides a Business Update	globenewswire.com
Tuesday, 12 November 2024
16:05	ICU Medical, Inc. and Otsuka Pharmaceutical Factory, Inc., a Subsidiary of Otsuka Holdings Co. Ltd., Announce Creation of a Joint Venture to Bolster IV Solutions Manufacturing and Innovation in North America	prnewswire.com
Wednesday, 6 November 2024
08:30	ICU Medical to Participate at the UBS Global Healthcare Conference	globenewswire.com
Friday, 1 November 2024
08:30	Record Monthly Enrollment Achieved in SeaStar Medical's Pivotal Adult AKI Trial	globenewswire.com
Thursday, 31 October 2024
08:30	SeaStar Medical Adds Second Hospital Customer for QUELIMMUNE	globenewswire.com
Monday, 28 October 2024
08:30	ICU Medical Announces Time of Third Quarter 2024 Earnings Conference Call	globenewswire.com
Friday, 25 October 2024
11:32	Economic Analysis Supporting Significant Hospitalization Cost Reduction with SeaStar Medical's QUELIMMUNE Pediatric Therapeutic Device Presented at ASN Kidney Week 2024 - Update	globenewswire.com
08:30	Economic Analysis Supporting Significant Hospitalization Cost Reduction with SeaStar Medical's QUELIMMUNE Pediatric Therapeutic Device Presented at ASN Kidney Week 2024	globenewswire.com
Tuesday, 22 October 2024
08:30	SeaStar Medical to Distribute QUELIMMUNE Directly to Hospital Customers	globenewswire.com
Friday, 18 October 2024
08:30	SeaStar Medical Announces that Enrollment in its Adult Acute Kidney Injury Pivotal Trial Has Exceeded the Halfway Point Toward an Interim Analysis	globenewswire.com
Tuesday, 15 October 2024
08:30	SeaStar Medical to Showcase New Mechanistic Data Highlighting the Immunomodulatory Effect of the Selective Cytopheretic Device in Acute Kidney Injury at ASN Kidney Week	globenewswire.com
Wednesday, 9 October 2024
08:30	SeaStar Medical to Present at the 2024 Maxim Healthcare Virtual Summit	globenewswire.com
Tuesday, 8 October 2024
08:30	SeaStar Medical Expands NEUTRALIZE-AKI Pivotal Trial Adding Two Premier Military Medical Facilities	globenewswire.com
Wednesday, 25 September 2024
11:45	ICU Medical's Stock Rises Despite Bivona Tracheostomy Tube Recall	zacks.com
08:30	SeaStar Medical Reports Enrollment Momentum in Its Pivotal Adult AKI Trial	globenewswire.com
Sunday, 15 September 2024
11:00	The Schall Law Firm Invites Investor Participation In A Securities Fraud Case Against SeaStar Medical Holding Corporation	accesswire.com
Saturday, 14 September 2024
11:00	SeaStar Medical Holding Corporation Is Being Sued For Violating Securities Regulations And Stockholders Are Invited To Help The Schall Law Firm	accesswire.com
Friday, 13 September 2024
11:00	The Schall Law Firm Urges Investors To Take Part In A Securities Fraud Case Against SeaStar Medical Holding Corporation	accesswire.com
Thursday, 12 September 2024
11:00	SeaStar Medical Holding Corporation Is Being Sued For Securities Law Violations And Stakeholders Are Invited To Reach Out To The Schall Law Firm	accesswire.com
Wednesday, 11 September 2024
11:00	The Schall Law Firm Urges Investor Participation In A Securities Fraud Case Against SeaStar Medical Holding Corporation	accesswire.com
Monday, 9 September 2024
11:00	The Schall Law Firm Wants Investors To Contribute To A Securities Fraud Lawsuit Against Seastar Medical Holding Corporation	accesswire.com
Saturday, 7 September 2024
11:00	SeaStar Medical Holding Corporation Is Being Sued For Violating Securities Laws And Shareholders With Losses Are Urged To Contact The Schall Law Firm	accesswire.com
Friday, 6 September 2024
16:40	SeaStar Medical Holding Corporation Sued for Securities Law Violations - Contact Levi & Korsinsky Before September 6, 2024 to Discuss Your Rights – ICU	accesswire.com
11:30	Class Action Filed Against SeaStar Medical Holding Corporation (ICU) - September 6, 2024 Deadline to Join - Contact Levi & Korsinsky	accesswire.com

Frequently Asked Questions (FAQ)

What's the price of SeaStar Medical Holding stock today?

One share of SeaStar Medical Holding stock can currently be purchased for approximately $0.81.
When is SeaStar Medical Holding's next earnings date?

Unfortunately, SeaStar Medical Holding's (ICU) next earnings date is currently unknown.
Does SeaStar Medical Holding pay dividends?

No, SeaStar Medical Holding does not pay dividends.
How much money does SeaStar Medical Holding make?

SeaStar Medical Holding has a market capitalization of 8.79M.
What is SeaStar Medical Holding's stock symbol?

SeaStar Medical Holding Corporation is traded on the NASDAQ under the ticker symbol "ICU".
What is SeaStar Medical Holding's primary industry?

Company operates in the Healthcare sector and Biotechnology industry.
How do i buy shares of SeaStar Medical Holding?

Shares of SeaStar Medical Holding can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
How many employees does SeaStar Medical Holding have?

As Jul 2024, SeaStar Medical Holding employs 12 workers, which is 33% more then previous quarter.
When SeaStar Medical Holding went public?

SeaStar Medical Holding Corporation is publicly traded company for more then 4 years since IPO on 18 Mar 2021.
What is SeaStar Medical Holding's official website?

The official website for SeaStar Medical Holding is seastarmedical.com.
Where are SeaStar Medical Holding's headquarters?

SeaStar Medical Holding is headquartered at 3513 Brighton Boulevard, Denver, CO.
How can i contact SeaStar Medical Holding?

SeaStar Medical Holding's mailing address is 3513 Brighton Boulevard, Denver, CO and company can be reached via phone at +84 44278100.

SeaStar Medical Holding Corporation

seastarmedical.com

Exchange:

NASDAQ

Full time employees:

Industry:

Biotechnology

Sector:

Healthcare

SeaStar Medical Holding Corporation, a medical device company, focuses on providing novel solutions and services to treat hyperinflammation and cytokine storm in critically ill patients. The company is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. It is developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure with and without LVAD; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is based in Denver, Colorado.

+84 44278100

3513 Brighton Boulevard
Denver, CO 80216

CIK: 0001831868
ISIN: US81256L1044
CUSIP: 81256L104